{"id":31948,"date":"2021-08-31T02:26:02","date_gmt":"2021-08-31T02:26:02","guid":{"rendered":"https:\/\/dailyhomeland.com\/?p=31948"},"modified":"2021-08-31T02:26:02","modified_gmt":"2021-08-31T02:26:02","slug":"granules-india-gets-health-canada-nod-to-market-arthritis-tablets","status":"publish","type":"post","link":"https:\/\/dailyhomeland.com\/?p=31948","title":{"rendered":"Granules India gets Health Canada nod to market arthritis tablets"},"content":{"rendered":"<p>Drug firm Granules India on Monday said it has received marketing nod from Health Canada for its Acetaminophen extended-release tablets used in the treatment of arthritis pain. The company has received approval from Health Canada for Acetaminophen extended-release tablets OTC, 650 mg, Granules India said in a regulatory filing.<\/p>\n<p>&#8220;We received the approval within eight months of filing. This is a step towards global expansion of our core molecules. The approval of Acetaminophen extended-release tablets OTC, 650mg&#8230;, is a good addition to our portfolio,&#8221; Granules USA, Inc &amp; Granules Pharmaceuticals, Inc Executive Director Priyanka Chigurupati said.<br \/>\nThe company will be launching the product in Canadian market soon, she added. The drug will be manufactured at the company&#8217;s manufacturing facility located in Gagillapur, Hyderabad, the filing said.<\/p>\n<p>Shares of Granules India Ltd were trading at Rs 335.90 per scrip on BSE, up 1.53 per cent from its previous close.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drug firm Granules India on Monday said it has received marketing nod from Health Canada for its Acetaminophen extended-release tablets used in the treatment of arthritis pain. The company has received approval from Health Canada for Acetaminophen extended-release tablets OTC, 650 mg, Granules India said in a regulatory filing. &#8220;We received the approval within eight [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":31950,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[44,48],"tags":[],"jetpack_featured_media_url":"https:\/\/www.bssnews.net\/assets\/news_photos\/2021\/08\/30\/image-14383-1630331730.jpg","jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/31948"}],"collection":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31948"}],"version-history":[{"count":1,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/31948\/revisions"}],"predecessor-version":[{"id":31949,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/31948\/revisions\/31949"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/media\/31950"}],"wp:attachment":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}